Related Experiment Video
Updated: Jan 23, 2026

06:35
Experimental Glaucoma Induced by Ocular Injection of Magnetic Microspheres
Published on: February 2, 2015
17.8K
[Pseudopemphigoid Induced by Topical Glaucoma Medications].
1Klinik für Augenheilkunde, Universitätsklinikum Düsseldorf, Düsseldorf.
Summary
Pseudopemphigoid, a condition causing conjunctival scarring, mimics mucous membrane pemphigoid. Glaucoma patients on topical therapy are often affected, necessitating careful diagnosis and treatment strategies.
Area of Science:
- Ophthalmology
- Dermatology
- Immunology
Background:
- Pseudopemphigoid presents as progressive conjunctival scarring and symblepharon formation.
- It is phenotypically indistinguishable from ocular mucous membrane pemphigoid.
- Ocular surface disorders and their treatments are potential triggers for pseudopemphigoid.
Purpose of the Study:
- To compare pseudopemphigoid and mucous membrane pemphigoid.
- To outline diagnostic approaches for suspected pseudopemphigoid in glaucoma patients.
- To present therapeutic strategies for pseudopemphigoid under topical glaucoma therapy.
Main Methods:
- Review of existing literature on pseudopemphigoid and mucous membrane pemphigoid.
- Comparison of clinical features, diagnostic criteria, and treatment outcomes.
- Analysis of patient populations, particularly those with glaucoma and topical antiglaucomatous therapy.
Main Results:
- Approximately 50% of pseudopemphigoid patients have a history of glaucoma treated with topical medications.
- Unilateral findings, absence of systemic disease signs, and a glaucoma history suggest pseudopemphigoid.
- Distinguishing pseudopemphigoid from true mucous membrane pemphigoid is crucial for appropriate management.
Conclusions:
- Pseudopemphigoid is a significant consideration in glaucoma patients experiencing conjunctival scarring.
- Early and accurate diagnosis is essential for effective management and prevention of severe ocular complications.
- Tailored therapeutic approaches are necessary for pseudopemphigoid, especially in the context of ongoing glaucoma treatment.
Related Concept Videos
Glaucoma: Overview
1.3K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.3K
Open Angle Glaucoma: Treatment
969
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
969
Angle Closure Glaucoma: Treatment
1.2K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.2K
Inhaled Medications
764
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
764
Endocarditis III: Medical Management
222
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
222
Myocarditis III: Medical Management
186
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
186

